Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Hyperlipoproteinemias

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 15 articles:
HTML format



Single Articles


    February 2024
  1. ALEXANDER VJ, Karwatowska-Prokopczuk E, Prohaska TA, Li L, et al
    Volanesorsen to Prevent Acute Pancreatitis in Hypertriglyceridemia.
    N Engl J Med. 2024;390:476-477.
    PubMed    


    April 2023
  2. ALEXANDER JH
    Benefits of Bempedoic Acid - Clearer Now.
    N Engl J Med. 2023;388:1425-1426.
    PubMed    


    November 2022
  3. O'DONOGHUE ML, Rosenson RS, Gencer B, Lopez JAG, et al
    Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease.
    N Engl J Med. 2022 Nov 6. doi: 10.1056/NEJMoa2211023.
    PubMed     Abstract available


  4. DAS PRADHAN A, Glynn RJ, Fruchart JC, MacFadyen JG, et al
    Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
    N Engl J Med. 2022 Nov 5. doi: 10.1056/NEJMoa2210645.
    PubMed     Abstract available


    March 2021
  5. GIBBONS GH, Seidman CE, Topol EJ
    Conquering Atherosclerotic Cardiovascular Disease - 50 Years of Progress.
    N Engl J Med. 2021;384:785-788.
    PubMed    


    February 2021
  6. RAAL FJ, Gaudet D, Gusarova V
    Evinacumab for Homozygous Familial Hypercholesterolemia. Reply.
    N Engl J Med. 2021;384:e17.
    PubMed    


  7. XU HG
    Evinacumab for Homozygous Familial Hypercholesterolemia.
    N Engl J Med. 2021;384:e17.
    PubMed    


  8. LUO F, Das A, Fang Z
    Evinacumab for Homozygous Familial Hypercholesterolemia.
    N Engl J Med. 2021;384:e17.
    PubMed    


  9. AGIRBASLI M
    Evinacumab for Homozygous Familial Hypercholesterolemia.
    N Engl J Med. 2021;384:e17.
    PubMed    


    January 2021
  10. GAUDET D, Ruzza A, Santos RD
    Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia. Reply.
    N Engl J Med. 2021;384:84-85.
    PubMed    


  11. SINGH A, Mittal S, Kazimuddin M
    Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia.
    N Engl J Med. 2021;384:84.
    PubMed    


    December 2020
  12. MARTIN SS
    Factoring in ANGPTL3 When LDL Is Refractory.
    N Engl J Med. 2020;383:2385-2386.
    PubMed    


    November 2020
  13. SHAW AT, Bauer TM, de Marinis F, Felip E, et al
    First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer.
    N Engl J Med. 2020;383:2018-2029.
    PubMed     Abstract available


  14. ROSENSON RS, Burgess LJ, Ebenbichler CF, Baum SJ, et al
    Evinacumab in Patients with Refractory Hypercholesterolemia.
    N Engl J Med. 2020 Nov 15. doi: 10.1056/NEJMoa2031049.
    PubMed     Abstract available


    October 2020
  15. DE FERRANTI SD
    Evolocumab in Children with Heterozygous Familial Hypercholesterolemia.
    N Engl J Med. 2020;383:1385-1386.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Hyperlipoproteinemias is free of charge.